UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2022

Commission File Number: 001-40488

Molecular Partners AG
(Translation of registrant's name into English)

Wagistrasse 14
8952 Zurich-Schlieren
Switzerland
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ]      Form 40-F [   ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):        

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):        

INCORPORATION BY REFERENCE 

 

Exhibits 99.1 and 99.2 to this Report on Form 6-K shall be deemed to be incorporated by reference into the registrant’s Registration Statement on Form F-3 (File No. 333-265960) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

EXHIBIT INDEX

 

Exhibit No. Description
      
99.1 Press Release dated August 25, 2022   
99.2 Half-Year Report

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

      Molecular Partners AG    
  (Registrant)
   
  
Date: August 25, 2022     /s/ PATRICK AMSTUTZ    
  Patrick Amstutz
  Chief Executive Officer
  
Molecular Partners (CE) (USOTC:MLLCF)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more Molecular Partners (CE) Charts.
Molecular Partners (CE) (USOTC:MLLCF)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more Molecular Partners (CE) Charts.